Holen Sie sich die Stockscreener-App
2.615
1.69%
-0.045
Schlusskurs vom Vortag:
$2.66
Offen:
$2.65
24-Stunden-Volumen:
77,258
Relative Volume:
0.10
Marktkapitalisierung:
$75.80M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-75.52M
KGV:
-1.0058
EPS:
-2.6
Netto-Cashflow:
$-56.92M
1W Leistung:
+2.15%
1M Leistung:
+11.75%
6M Leistung:
-86.79%
1J Leistung:
-81.97%
1-Tages-Spanne:
$2.57
$2.68
1-Wochen-Bereich:
$2.52
$2.715
52-Wochen-Spanne:
$1.25
$32.41
Aerovate Therapeutics Inc Stock (AVTE) Company Profile
Firmenname
Aerovate Therapeutics Inc
Sektor
Branche
Telefon
617-443-2400
Adresse
930 WINTER STREET, WALTHAM
Vergleichen Sie AVTE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| AVTE | 2.615 | 75.80M | 0 | -75.52M | -56.92M | -2.60 |
| VRTX | 449.99 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 747.50 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 593.04 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 246.22 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 107.19 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2022-12-06 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Outperform |
| 2022-08-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-02-11 | Eingeleitet | BTIG Research | Buy |
| 2021-07-26 | Eingeleitet | Cowen | Outperform |
| 2021-07-26 | Eingeleitet | Evercore ISI | Outperform |
| 2021-07-26 | Eingeleitet | Jefferies | Buy |
| 2021-07-26 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Aerovate Therapeutics Inc Aktie (AVTE) Neueste Nachrichten
GSA Capital Partners LLP Has $865,000 Stock Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Declines By 17.3% - MarketBeat
Wedbush Research Analysts Raise Earnings Estimates for AVTE - Defense World
What is Wedbush's Forecast for AVTE FY2024 Earnings? - MarketBeat
Aerovate Therapeutics Reports Q3 Loss Amid Strategic Shift - TipRanks
Finansavisen - Finansavisen
Jade Biosciences’ Merger with Aerovate Therapeutics - Global Legal Chronicle
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc. – AVTE - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ATSG, STAF, AVTE on Behalf of Shareholders - Marketscreener.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC – MPAD), Aerovate Therapeutics, Inc. (Nasdaq – AVTE), Outbrain Inc. (Nasd - ForexTV.com
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Marketscreener.com
INVESTOR ALERT: The M&A Class Action Firm Investigates the Merger of Aerovate Therapeutics, Inc.AVTE - PR Newswire
Aerovate Therapeutics Enters into Merger Agreement with Jade Biosciences - Defense World
How Fairmount’s Paragon incubator steered two more companies to NASDAQ - BioCentury
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE and PFIE on Behalf of Shareholders - Marketscreener.com
Kuehn Law Encourages OB, AVTE, B, and MNTX Investors to Contact Law Firm - The Malaysian Reserve
SEC Form 425 filed by Aerovate Therapeutics Inc. - Quantisnow
Form 425 Aerovate Therapeutics, Filed by: Aerovate Therapeutics, Inc. - StreetInsider.com
Aerovate (AVTE) Shares Rally As Market Responds To A Merger Agreement - Stocks Telegraph
Jade, another biotech spinout of Paragon, to merge with Aerovate - BioPharma Dive
Jade Biosciences and Aerovate announce merger deal - Investing.com
AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders - Business Wire
Aerovate to Merge With Jade Biosciences, Pursue Kidney Treatment - MarketWatch
Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders - Business Wire
Aerovate climbs on all-stock merger deal with Jade - MSN
Aerovate stock rises on all-stock merger deal (AVTE:NASDAQ) - Seeking Alpha
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement - GlobeNewswire
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Down 21.4% in October - MarketBeat
Aerovate Therapeutics regains Nasdaq compliance - Investing.com India
Aerovate Therapeutics regains Nasdaq compliance By Investing.com - Investing.com Canada
Hypertension Clinical Trials 2024: FDA Approvals, Medication, Therapies, MOA, ROA, Companies by DelveInsight | Quantum Genomics, CinCor Pharma, Mineralys Therapeutics, Alnylam Therapeutics, Novartis - The Globe and Mail
Cubist Systematic Strategies LLC Makes New Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Analyzing Aerovate Therapeutics Inc (AVTE) After Recent Trading Activity - Knox Daily
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Short Interest Update - MarketBeat
Aerovate Therapeutics announces board member resignation - Investing.com India
Aerovate Therapeutics announces board member resignation By Investing.com - Investing.com UK
XTX Topco Ltd Invests $35,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Short Interest in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Decreases By 15.7% - MarketBeat
Bank of New York Mellon Corp Increases Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Deerfield Management Company L.P. Series C Takes Position in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Deerfield Management Company L.P. Series C Acquires New Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Affinity Asset Advisors LLC Makes New $332,000 Investment in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Market Highlights: Alector Inc (ALEC) Ends on a Low Note at 5.45 - The Dwinnex
AlgoTx completes pivotal phase 2 trial for ground-breaking CIPN treatment - PharmaTimes
Why AeroVironment Shares Are Flying Higher Today - sharewise
Alector (NASDAQ:ALEC) Shares Down 5.6% - Defense World
Defense Stock Soars on ‘Rare Move’ From the U.S. Army - Barron's
AeroVironment (NASDAQ:AVAV) Shares Gap Up to $182.76 - Defense World
AeroVironment Stock Is Rising Monday: What's Driving The Action? - Benzinga
Altitude Group’s AGM: Mixed Shareholder Decisions - TipRanks
Finanzdaten der Aerovate Therapeutics Inc-Aktie (AVTE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):